More importantly, a common intronic deletion polymorphism of BIM that produces BIM isoforms lacking the pro-apoptotic BH3 domain has been associated with resistance to TKIs in CML [87]. This evidence concerns the gene BCL2L11 and chronic myelogenous leukemia, BCR-ABL1 positive.